"Value of Hope" Study of Patient and Physician Preferences Published in Value in Health
The “Value of Hope” study, examining patient and physician preferences for durable survival, was recently published in a special issue of Value in Health– focusing on value assessment frameworks.
To read the complete study by PHE authors Jason Shafrin, Taylor Schwartz, John Romley, et al, please click here.
By: Jason Shafrin, PhD Sr. Director, Policy and Economics and Jacki Chou, MPL Senior Director, Policy and Economics The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the heterogeneity in patient clinical needs and preferences.